Pharma & Healthcare
Global Red Blood Cell Products Market Research Report 2025
- Apr 16, 25
- ID: 195352
- Pages: 98
- Figures: 99
- Views: 2
The global market for Red Blood Cell Products was valued at US$ 20500 million in the year 2024 and is projected to reach a revised size of US$ 24650 million by 2031, growing at a CAGR of 2.7% during the forecast period.
Red blood cell products are component blood made by separating red blood cells from whole blood through techniques such as centrifugation, filtration, washing, and freezing, and adding anticoagulants or preservation solutions. Its main component is hemoglobin rich red blood cells, which have complete oxygen carrying function and usually remove most of the plasma, white blood cells or platelets. It is mainly used for patients with normal blood volume but need to improve blood oxygen carrying capacity, such as acute bleeding, chronic anemia, surgical blood preparation, etc. Common types include red blood cell suspension, concentrated red blood cells, washed red blood cells, frozen red blood cells, irradiated red blood cells, etc.
Red blood cell products, as an important component of the blood products industry, have shown a stable growth trend in their market size. The aging population is a long-term factor driving market growth. The treatment of age-related diseases such as orthopedic and cardiovascular diseases often requires support from red blood cell products. The changes in disease spectrum also affect the market pattern of red blood cell products. Chronic diseases such as renal insufficiency, malignant tumors, and inflammatory bowel disease are often accompanied by chronic anemia, requiring regular infusion of red blood cells to maintain quality of life. The development of trauma and emergency medicine has enabled more severe trauma patients to receive treatment, and the management of major bleeding cannot be separated from the support of red blood cell products. In addition, advances in medical technology, increased medical expenses, and improved medical security have also promoted the development of the market. The global competitive landscape is highly concentrated and stable, with multinational giants such as CSL, Grifols, Takeda, Octapharma, etc., occupying an absolute advantage in the international market with their global layout, complete product lines, and advanced technology. They not only have a huge plasma collection network, but also continue to invest in research and development innovation, leading the technological development direction of red blood cell products. The competition for plasma station resources is the core focus of competition in the red blood cell products industry. Enterprises are strengthening their layout in areas with abundant plasma station resources, increasing the number of plasma stations through new construction or acquisition, in order to consolidate their advantage in raw material supply. In the future, the market size will continue to grow, but the growth rate may tend to flatten out. Upgrading product structure, technological innovation, improving plasma comprehensive utilization level, expanding clinical applications, increasing industry concentration, international competition and cooperation, and evolving policy environment will become the main development trends in the market. In the future, enterprises with the ability to guarantee raw materials, technological innovation, and market sensitivity will gain competitive advantages and lead the industry towards high-quality development. Despite facing multiple challenges such as raw material limitations, policy constraints, and alternative technologies, the long-term prospects of this market remain broad based on the irreplaceable position of red blood cells in clinical treatment and the continuously growing medical demand.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Red Blood Cell Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Red Blood Cell Products.
The Red Blood Cell Products market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Red Blood Cell Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Red Blood Cell Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Emergent BioSolutions
Kamada
Takeda Pharmaceutical
Kedrion
Grifols
Hemophilia Federation Europe
CSL Behring
Octapharma
LFB Group
American Red Cross
Biotest
Sangamo Therapeutics
China National Biotec Group
Hualan Biological
Shanghai RAAS Blood Products
Tiantan Biological
Bohui Innovation
Pilin Biological
Weiguang Biological
Boyaa Bio-pharmaceutical
Segment by Type
Red Blood Cell Suspension
Concentrated Red Blood Cells
Washed Red Blood Cells
Irradiated Red Blood Cells
Frozen Red Blood Cells
Others
Segment by Application
Anemia Treatment
Acute Hemorrhage
Blood Disease Supportive Treatment
Special Disease Management
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Red Blood Cell Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Red Blood Cell Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Red blood cell products are component blood made by separating red blood cells from whole blood through techniques such as centrifugation, filtration, washing, and freezing, and adding anticoagulants or preservation solutions. Its main component is hemoglobin rich red blood cells, which have complete oxygen carrying function and usually remove most of the plasma, white blood cells or platelets. It is mainly used for patients with normal blood volume but need to improve blood oxygen carrying capacity, such as acute bleeding, chronic anemia, surgical blood preparation, etc. Common types include red blood cell suspension, concentrated red blood cells, washed red blood cells, frozen red blood cells, irradiated red blood cells, etc.
Red blood cell products, as an important component of the blood products industry, have shown a stable growth trend in their market size. The aging population is a long-term factor driving market growth. The treatment of age-related diseases such as orthopedic and cardiovascular diseases often requires support from red blood cell products. The changes in disease spectrum also affect the market pattern of red blood cell products. Chronic diseases such as renal insufficiency, malignant tumors, and inflammatory bowel disease are often accompanied by chronic anemia, requiring regular infusion of red blood cells to maintain quality of life. The development of trauma and emergency medicine has enabled more severe trauma patients to receive treatment, and the management of major bleeding cannot be separated from the support of red blood cell products. In addition, advances in medical technology, increased medical expenses, and improved medical security have also promoted the development of the market. The global competitive landscape is highly concentrated and stable, with multinational giants such as CSL, Grifols, Takeda, Octapharma, etc., occupying an absolute advantage in the international market with their global layout, complete product lines, and advanced technology. They not only have a huge plasma collection network, but also continue to invest in research and development innovation, leading the technological development direction of red blood cell products. The competition for plasma station resources is the core focus of competition in the red blood cell products industry. Enterprises are strengthening their layout in areas with abundant plasma station resources, increasing the number of plasma stations through new construction or acquisition, in order to consolidate their advantage in raw material supply. In the future, the market size will continue to grow, but the growth rate may tend to flatten out. Upgrading product structure, technological innovation, improving plasma comprehensive utilization level, expanding clinical applications, increasing industry concentration, international competition and cooperation, and evolving policy environment will become the main development trends in the market. In the future, enterprises with the ability to guarantee raw materials, technological innovation, and market sensitivity will gain competitive advantages and lead the industry towards high-quality development. Despite facing multiple challenges such as raw material limitations, policy constraints, and alternative technologies, the long-term prospects of this market remain broad based on the irreplaceable position of red blood cells in clinical treatment and the continuously growing medical demand.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Red Blood Cell Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Red Blood Cell Products.
The Red Blood Cell Products market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Red Blood Cell Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Red Blood Cell Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Emergent BioSolutions
Kamada
Takeda Pharmaceutical
Kedrion
Grifols
Hemophilia Federation Europe
CSL Behring
Octapharma
LFB Group
American Red Cross
Biotest
Sangamo Therapeutics
China National Biotec Group
Hualan Biological
Shanghai RAAS Blood Products
Tiantan Biological
Bohui Innovation
Pilin Biological
Weiguang Biological
Boyaa Bio-pharmaceutical
Segment by Type
Red Blood Cell Suspension
Concentrated Red Blood Cells
Washed Red Blood Cells
Irradiated Red Blood Cells
Frozen Red Blood Cells
Others
Segment by Application
Anemia Treatment
Acute Hemorrhage
Blood Disease Supportive Treatment
Special Disease Management
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Red Blood Cell Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Red Blood Cell Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Red Blood Cell Products Market Overview
1.1 Product Definition
1.2 Red Blood Cell Products by Type
1.2.1 Global Red Blood Cell Products Market Value Comparison by Type (2024 VS 2031)
1.2.2 Red Blood Cell Suspension
1.2.3 Concentrated Red Blood Cells
1.2.4 Washed Red Blood Cells
1.2.5 Irradiated Red Blood Cells
1.2.6 Frozen Red Blood Cells
1.2.7 Others
1.3 Red Blood Cell Products by Application
1.3.1 Global Red Blood Cell Products Market Value by Application (2024 VS 2031)
1.3.2 Anemia Treatment
1.3.3 Acute Hemorrhage
1.3.4 Blood Disease Supportive Treatment
1.3.5 Special Disease Management
1.4 Global Red Blood Cell Products Market Size Estimates and Forecasts
1.4.1 Global Red Blood Cell Products Revenue 2020-2031
1.4.2 Global Red Blood Cell Products Sales 2020-2031
1.4.3 Global Red Blood Cell Products Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Red Blood Cell Products Market Competition by Manufacturers
2.1 Global Red Blood Cell Products Sales Market Share by Manufacturers (2020-2025)
2.2 Global Red Blood Cell Products Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Red Blood Cell Products Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Red Blood Cell Products, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Red Blood Cell Products, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Red Blood Cell Products, Product Type & Application
2.7 Global Key Manufacturers of Red Blood Cell Products, Date of Enter into This Industry
2.8 Global Red Blood Cell Products Market Competitive Situation and Trends
2.8.1 Global Red Blood Cell Products Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Red Blood Cell Products Players Market Share by Revenue
2.8.3 Global Red Blood Cell Products Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Red Blood Cell Products Market Scenario by Region
3.1 Global Red Blood Cell Products Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Red Blood Cell Products Sales by Region: 2020-2031
3.2.1 Global Red Blood Cell Products Sales by Region: 2020-2025
3.2.2 Global Red Blood Cell Products Sales by Region: 2026-2031
3.3 Global Red Blood Cell Products Revenue by Region: 2020-2031
3.3.1 Global Red Blood Cell Products Revenue by Region: 2020-2025
3.3.2 Global Red Blood Cell Products Revenue by Region: 2026-2031
3.4 North America Red Blood Cell Products Market Facts & Figures by Country
3.4.1 North America Red Blood Cell Products Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Red Blood Cell Products Sales by Country (2020-2031)
3.4.3 North America Red Blood Cell Products Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Red Blood Cell Products Market Facts & Figures by Country
3.5.1 Europe Red Blood Cell Products Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Red Blood Cell Products Sales by Country (2020-2031)
3.5.3 Europe Red Blood Cell Products Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Red Blood Cell Products Market Facts & Figures by Region
3.6.1 Asia Pacific Red Blood Cell Products Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Red Blood Cell Products Sales by Region (2020-2031)
3.6.3 Asia Pacific Red Blood Cell Products Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Red Blood Cell Products Market Facts & Figures by Country
3.7.1 Latin America Red Blood Cell Products Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Red Blood Cell Products Sales by Country (2020-2031)
3.7.3 Latin America Red Blood Cell Products Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Red Blood Cell Products Market Facts & Figures by Country
3.8.1 Middle East and Africa Red Blood Cell Products Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Red Blood Cell Products Sales by Country (2020-2031)
3.8.3 Middle East and Africa Red Blood Cell Products Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Red Blood Cell Products Sales by Type (2020-2031)
4.1.1 Global Red Blood Cell Products Sales by Type (2020-2025)
4.1.2 Global Red Blood Cell Products Sales by Type (2026-2031)
4.1.3 Global Red Blood Cell Products Sales Market Share by Type (2020-2031)
4.2 Global Red Blood Cell Products Revenue by Type (2020-2031)
4.2.1 Global Red Blood Cell Products Revenue by Type (2020-2025)
4.2.2 Global Red Blood Cell Products Revenue by Type (2026-2031)
4.2.3 Global Red Blood Cell Products Revenue Market Share by Type (2020-2031)
4.3 Global Red Blood Cell Products Price by Type (2020-2031)
5 Segment by Application
5.1 Global Red Blood Cell Products Sales by Application (2020-2031)
5.1.1 Global Red Blood Cell Products Sales by Application (2020-2025)
5.1.2 Global Red Blood Cell Products Sales by Application (2026-2031)
5.1.3 Global Red Blood Cell Products Sales Market Share by Application (2020-2031)
5.2 Global Red Blood Cell Products Revenue by Application (2020-2031)
5.2.1 Global Red Blood Cell Products Revenue by Application (2020-2025)
5.2.2 Global Red Blood Cell Products Revenue by Application (2026-2031)
5.2.3 Global Red Blood Cell Products Revenue Market Share by Application (2020-2031)
5.3 Global Red Blood Cell Products Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Emergent BioSolutions
6.1.1 Emergent BioSolutions Company Information
6.1.2 Emergent BioSolutions Description and Business Overview
6.1.3 Emergent BioSolutions Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Emergent BioSolutions Red Blood Cell Products Product Portfolio
6.1.5 Emergent BioSolutions Recent Developments/Updates
6.2 Kamada
6.2.1 Kamada Company Information
6.2.2 Kamada Description and Business Overview
6.2.3 Kamada Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Kamada Red Blood Cell Products Product Portfolio
6.2.5 Kamada Recent Developments/Updates
6.3 Takeda Pharmaceutical
6.3.1 Takeda Pharmaceutical Company Information
6.3.2 Takeda Pharmaceutical Description and Business Overview
6.3.3 Takeda Pharmaceutical Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Takeda Pharmaceutical Red Blood Cell Products Product Portfolio
6.3.5 Takeda Pharmaceutical Recent Developments/Updates
6.4 Kedrion
6.4.1 Kedrion Company Information
6.4.2 Kedrion Description and Business Overview
6.4.3 Kedrion Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Kedrion Red Blood Cell Products Product Portfolio
6.4.5 Kedrion Recent Developments/Updates
6.5 Grifols
6.5.1 Grifols Company Information
6.5.2 Grifols Description and Business Overview
6.5.3 Grifols Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Grifols Red Blood Cell Products Product Portfolio
6.5.5 Grifols Recent Developments/Updates
6.6 Hemophilia Federation Europe
6.6.1 Hemophilia Federation Europe Company Information
6.6.2 Hemophilia Federation Europe Description and Business Overview
6.6.3 Hemophilia Federation Europe Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hemophilia Federation Europe Red Blood Cell Products Product Portfolio
6.6.5 Hemophilia Federation Europe Recent Developments/Updates
6.7 CSL Behring
6.7.1 CSL Behring Company Information
6.7.2 CSL Behring Description and Business Overview
6.7.3 CSL Behring Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CSL Behring Red Blood Cell Products Product Portfolio
6.7.5 CSL Behring Recent Developments/Updates
6.8 Octapharma
6.8.1 Octapharma Company Information
6.8.2 Octapharma Description and Business Overview
6.8.3 Octapharma Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Octapharma Red Blood Cell Products Product Portfolio
6.8.5 Octapharma Recent Developments/Updates
6.9 LFB Group
6.9.1 LFB Group Company Information
6.9.2 LFB Group Description and Business Overview
6.9.3 LFB Group Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.9.4 LFB Group Red Blood Cell Products Product Portfolio
6.9.5 LFB Group Recent Developments/Updates
6.10 American Red Cross
6.10.1 American Red Cross Company Information
6.10.2 American Red Cross Description and Business Overview
6.10.3 American Red Cross Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.10.4 American Red Cross Red Blood Cell Products Product Portfolio
6.10.5 American Red Cross Recent Developments/Updates
6.11 Biotest
6.11.1 Biotest Company Information
6.11.2 Biotest Description and Business Overview
6.11.3 Biotest Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Biotest Red Blood Cell Products Product Portfolio
6.11.5 Biotest Recent Developments/Updates
6.12 Sangamo Therapeutics
6.12.1 Sangamo Therapeutics Company Information
6.12.2 Sangamo Therapeutics Description and Business Overview
6.12.3 Sangamo Therapeutics Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sangamo Therapeutics Red Blood Cell Products Product Portfolio
6.12.5 Sangamo Therapeutics Recent Developments/Updates
6.13 China National Biotec Group
6.13.1 China National Biotec Group Company Information
6.13.2 China National Biotec Group Description and Business Overview
6.13.3 China National Biotec Group Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.13.4 China National Biotec Group Red Blood Cell Products Product Portfolio
6.13.5 China National Biotec Group Recent Developments/Updates
6.14 Hualan Biological
6.14.1 Hualan Biological Company Information
6.14.2 Hualan Biological Description and Business Overview
6.14.3 Hualan Biological Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hualan Biological Red Blood Cell Products Product Portfolio
6.14.5 Hualan Biological Recent Developments/Updates
6.15 Shanghai RAAS Blood Products
6.15.1 Shanghai RAAS Blood Products Company Information
6.15.2 Shanghai RAAS Blood Products Description and Business Overview
6.15.3 Shanghai RAAS Blood Products Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Shanghai RAAS Blood Products Red Blood Cell Products Product Portfolio
6.15.5 Shanghai RAAS Blood Products Recent Developments/Updates
6.16 Tiantan Biological
6.16.1 Tiantan Biological Company Information
6.16.2 Tiantan Biological Description and Business Overview
6.16.3 Tiantan Biological Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Tiantan Biological Red Blood Cell Products Product Portfolio
6.16.5 Tiantan Biological Recent Developments/Updates
6.17 Bohui Innovation
6.17.1 Bohui Innovation Company Information
6.17.2 Bohui Innovation Description and Business Overview
6.17.3 Bohui Innovation Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Bohui Innovation Red Blood Cell Products Product Portfolio
6.17.5 Bohui Innovation Recent Developments/Updates
6.18 Pilin Biological
6.18.1 Pilin Biological Company Information
6.18.2 Pilin Biological Description and Business Overview
6.18.3 Pilin Biological Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Pilin Biological Red Blood Cell Products Product Portfolio
6.18.5 Pilin Biological Recent Developments/Updates
6.19 Weiguang Biological
6.19.1 Weiguang Biological Company Information
6.19.2 Weiguang Biological Description and Business Overview
6.19.3 Weiguang Biological Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Weiguang Biological Red Blood Cell Products Product Portfolio
6.19.5 Weiguang Biological Recent Developments/Updates
6.20 Boyaa Bio-pharmaceutical
6.20.1 Boyaa Bio-pharmaceutical Company Information
6.20.2 Boyaa Bio-pharmaceutical Description and Business Overview
6.20.3 Boyaa Bio-pharmaceutical Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Boyaa Bio-pharmaceutical Red Blood Cell Products Product Portfolio
6.20.5 Boyaa Bio-pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Red Blood Cell Products Industry Chain Analysis
7.2 Red Blood Cell Products Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Red Blood Cell Products Production Mode & Process Analysis
7.4 Red Blood Cell Products Sales and Marketing
7.4.1 Red Blood Cell Products Sales Channels
7.4.2 Red Blood Cell Products Distributors
7.5 Red Blood Cell Products Customer Analysis
8 Red Blood Cell Products Market Dynamics
8.1 Red Blood Cell Products Industry Trends
8.2 Red Blood Cell Products Market Drivers
8.3 Red Blood Cell Products Market Challenges
8.4 Red Blood Cell Products Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Red Blood Cell Products by Type
1.2.1 Global Red Blood Cell Products Market Value Comparison by Type (2024 VS 2031)
1.2.2 Red Blood Cell Suspension
1.2.3 Concentrated Red Blood Cells
1.2.4 Washed Red Blood Cells
1.2.5 Irradiated Red Blood Cells
1.2.6 Frozen Red Blood Cells
1.2.7 Others
1.3 Red Blood Cell Products by Application
1.3.1 Global Red Blood Cell Products Market Value by Application (2024 VS 2031)
1.3.2 Anemia Treatment
1.3.3 Acute Hemorrhage
1.3.4 Blood Disease Supportive Treatment
1.3.5 Special Disease Management
1.4 Global Red Blood Cell Products Market Size Estimates and Forecasts
1.4.1 Global Red Blood Cell Products Revenue 2020-2031
1.4.2 Global Red Blood Cell Products Sales 2020-2031
1.4.3 Global Red Blood Cell Products Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Red Blood Cell Products Market Competition by Manufacturers
2.1 Global Red Blood Cell Products Sales Market Share by Manufacturers (2020-2025)
2.2 Global Red Blood Cell Products Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Red Blood Cell Products Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Red Blood Cell Products, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Red Blood Cell Products, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Red Blood Cell Products, Product Type & Application
2.7 Global Key Manufacturers of Red Blood Cell Products, Date of Enter into This Industry
2.8 Global Red Blood Cell Products Market Competitive Situation and Trends
2.8.1 Global Red Blood Cell Products Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Red Blood Cell Products Players Market Share by Revenue
2.8.3 Global Red Blood Cell Products Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Red Blood Cell Products Market Scenario by Region
3.1 Global Red Blood Cell Products Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Red Blood Cell Products Sales by Region: 2020-2031
3.2.1 Global Red Blood Cell Products Sales by Region: 2020-2025
3.2.2 Global Red Blood Cell Products Sales by Region: 2026-2031
3.3 Global Red Blood Cell Products Revenue by Region: 2020-2031
3.3.1 Global Red Blood Cell Products Revenue by Region: 2020-2025
3.3.2 Global Red Blood Cell Products Revenue by Region: 2026-2031
3.4 North America Red Blood Cell Products Market Facts & Figures by Country
3.4.1 North America Red Blood Cell Products Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Red Blood Cell Products Sales by Country (2020-2031)
3.4.3 North America Red Blood Cell Products Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Red Blood Cell Products Market Facts & Figures by Country
3.5.1 Europe Red Blood Cell Products Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Red Blood Cell Products Sales by Country (2020-2031)
3.5.3 Europe Red Blood Cell Products Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Red Blood Cell Products Market Facts & Figures by Region
3.6.1 Asia Pacific Red Blood Cell Products Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Red Blood Cell Products Sales by Region (2020-2031)
3.6.3 Asia Pacific Red Blood Cell Products Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Red Blood Cell Products Market Facts & Figures by Country
3.7.1 Latin America Red Blood Cell Products Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Red Blood Cell Products Sales by Country (2020-2031)
3.7.3 Latin America Red Blood Cell Products Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Red Blood Cell Products Market Facts & Figures by Country
3.8.1 Middle East and Africa Red Blood Cell Products Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Red Blood Cell Products Sales by Country (2020-2031)
3.8.3 Middle East and Africa Red Blood Cell Products Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Red Blood Cell Products Sales by Type (2020-2031)
4.1.1 Global Red Blood Cell Products Sales by Type (2020-2025)
4.1.2 Global Red Blood Cell Products Sales by Type (2026-2031)
4.1.3 Global Red Blood Cell Products Sales Market Share by Type (2020-2031)
4.2 Global Red Blood Cell Products Revenue by Type (2020-2031)
4.2.1 Global Red Blood Cell Products Revenue by Type (2020-2025)
4.2.2 Global Red Blood Cell Products Revenue by Type (2026-2031)
4.2.3 Global Red Blood Cell Products Revenue Market Share by Type (2020-2031)
4.3 Global Red Blood Cell Products Price by Type (2020-2031)
5 Segment by Application
5.1 Global Red Blood Cell Products Sales by Application (2020-2031)
5.1.1 Global Red Blood Cell Products Sales by Application (2020-2025)
5.1.2 Global Red Blood Cell Products Sales by Application (2026-2031)
5.1.3 Global Red Blood Cell Products Sales Market Share by Application (2020-2031)
5.2 Global Red Blood Cell Products Revenue by Application (2020-2031)
5.2.1 Global Red Blood Cell Products Revenue by Application (2020-2025)
5.2.2 Global Red Blood Cell Products Revenue by Application (2026-2031)
5.2.3 Global Red Blood Cell Products Revenue Market Share by Application (2020-2031)
5.3 Global Red Blood Cell Products Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Emergent BioSolutions
6.1.1 Emergent BioSolutions Company Information
6.1.2 Emergent BioSolutions Description and Business Overview
6.1.3 Emergent BioSolutions Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Emergent BioSolutions Red Blood Cell Products Product Portfolio
6.1.5 Emergent BioSolutions Recent Developments/Updates
6.2 Kamada
6.2.1 Kamada Company Information
6.2.2 Kamada Description and Business Overview
6.2.3 Kamada Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Kamada Red Blood Cell Products Product Portfolio
6.2.5 Kamada Recent Developments/Updates
6.3 Takeda Pharmaceutical
6.3.1 Takeda Pharmaceutical Company Information
6.3.2 Takeda Pharmaceutical Description and Business Overview
6.3.3 Takeda Pharmaceutical Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Takeda Pharmaceutical Red Blood Cell Products Product Portfolio
6.3.5 Takeda Pharmaceutical Recent Developments/Updates
6.4 Kedrion
6.4.1 Kedrion Company Information
6.4.2 Kedrion Description and Business Overview
6.4.3 Kedrion Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Kedrion Red Blood Cell Products Product Portfolio
6.4.5 Kedrion Recent Developments/Updates
6.5 Grifols
6.5.1 Grifols Company Information
6.5.2 Grifols Description and Business Overview
6.5.3 Grifols Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Grifols Red Blood Cell Products Product Portfolio
6.5.5 Grifols Recent Developments/Updates
6.6 Hemophilia Federation Europe
6.6.1 Hemophilia Federation Europe Company Information
6.6.2 Hemophilia Federation Europe Description and Business Overview
6.6.3 Hemophilia Federation Europe Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hemophilia Federation Europe Red Blood Cell Products Product Portfolio
6.6.5 Hemophilia Federation Europe Recent Developments/Updates
6.7 CSL Behring
6.7.1 CSL Behring Company Information
6.7.2 CSL Behring Description and Business Overview
6.7.3 CSL Behring Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CSL Behring Red Blood Cell Products Product Portfolio
6.7.5 CSL Behring Recent Developments/Updates
6.8 Octapharma
6.8.1 Octapharma Company Information
6.8.2 Octapharma Description and Business Overview
6.8.3 Octapharma Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Octapharma Red Blood Cell Products Product Portfolio
6.8.5 Octapharma Recent Developments/Updates
6.9 LFB Group
6.9.1 LFB Group Company Information
6.9.2 LFB Group Description and Business Overview
6.9.3 LFB Group Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.9.4 LFB Group Red Blood Cell Products Product Portfolio
6.9.5 LFB Group Recent Developments/Updates
6.10 American Red Cross
6.10.1 American Red Cross Company Information
6.10.2 American Red Cross Description and Business Overview
6.10.3 American Red Cross Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.10.4 American Red Cross Red Blood Cell Products Product Portfolio
6.10.5 American Red Cross Recent Developments/Updates
6.11 Biotest
6.11.1 Biotest Company Information
6.11.2 Biotest Description and Business Overview
6.11.3 Biotest Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Biotest Red Blood Cell Products Product Portfolio
6.11.5 Biotest Recent Developments/Updates
6.12 Sangamo Therapeutics
6.12.1 Sangamo Therapeutics Company Information
6.12.2 Sangamo Therapeutics Description and Business Overview
6.12.3 Sangamo Therapeutics Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sangamo Therapeutics Red Blood Cell Products Product Portfolio
6.12.5 Sangamo Therapeutics Recent Developments/Updates
6.13 China National Biotec Group
6.13.1 China National Biotec Group Company Information
6.13.2 China National Biotec Group Description and Business Overview
6.13.3 China National Biotec Group Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.13.4 China National Biotec Group Red Blood Cell Products Product Portfolio
6.13.5 China National Biotec Group Recent Developments/Updates
6.14 Hualan Biological
6.14.1 Hualan Biological Company Information
6.14.2 Hualan Biological Description and Business Overview
6.14.3 Hualan Biological Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hualan Biological Red Blood Cell Products Product Portfolio
6.14.5 Hualan Biological Recent Developments/Updates
6.15 Shanghai RAAS Blood Products
6.15.1 Shanghai RAAS Blood Products Company Information
6.15.2 Shanghai RAAS Blood Products Description and Business Overview
6.15.3 Shanghai RAAS Blood Products Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Shanghai RAAS Blood Products Red Blood Cell Products Product Portfolio
6.15.5 Shanghai RAAS Blood Products Recent Developments/Updates
6.16 Tiantan Biological
6.16.1 Tiantan Biological Company Information
6.16.2 Tiantan Biological Description and Business Overview
6.16.3 Tiantan Biological Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Tiantan Biological Red Blood Cell Products Product Portfolio
6.16.5 Tiantan Biological Recent Developments/Updates
6.17 Bohui Innovation
6.17.1 Bohui Innovation Company Information
6.17.2 Bohui Innovation Description and Business Overview
6.17.3 Bohui Innovation Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Bohui Innovation Red Blood Cell Products Product Portfolio
6.17.5 Bohui Innovation Recent Developments/Updates
6.18 Pilin Biological
6.18.1 Pilin Biological Company Information
6.18.2 Pilin Biological Description and Business Overview
6.18.3 Pilin Biological Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Pilin Biological Red Blood Cell Products Product Portfolio
6.18.5 Pilin Biological Recent Developments/Updates
6.19 Weiguang Biological
6.19.1 Weiguang Biological Company Information
6.19.2 Weiguang Biological Description and Business Overview
6.19.3 Weiguang Biological Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Weiguang Biological Red Blood Cell Products Product Portfolio
6.19.5 Weiguang Biological Recent Developments/Updates
6.20 Boyaa Bio-pharmaceutical
6.20.1 Boyaa Bio-pharmaceutical Company Information
6.20.2 Boyaa Bio-pharmaceutical Description and Business Overview
6.20.3 Boyaa Bio-pharmaceutical Red Blood Cell Products Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Boyaa Bio-pharmaceutical Red Blood Cell Products Product Portfolio
6.20.5 Boyaa Bio-pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Red Blood Cell Products Industry Chain Analysis
7.2 Red Blood Cell Products Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Red Blood Cell Products Production Mode & Process Analysis
7.4 Red Blood Cell Products Sales and Marketing
7.4.1 Red Blood Cell Products Sales Channels
7.4.2 Red Blood Cell Products Distributors
7.5 Red Blood Cell Products Customer Analysis
8 Red Blood Cell Products Market Dynamics
8.1 Red Blood Cell Products Industry Trends
8.2 Red Blood Cell Products Market Drivers
8.3 Red Blood Cell Products Market Challenges
8.4 Red Blood Cell Products Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Red Blood Cell Products Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Red Blood Cell Products Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Red Blood Cell Products Market Competitive Situation by Manufacturers in 2024
Table 4. Global Red Blood Cell Products Sales (Units) of Key Manufacturers (2020-2025)
Table 5. Global Red Blood Cell Products Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Red Blood Cell Products Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Red Blood Cell Products Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Red Blood Cell Products Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Red Blood Cell Products, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Red Blood Cell Products, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Red Blood Cell Products, Product Type & Application
Table 12. Global Key Manufacturers of Red Blood Cell Products, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Red Blood Cell Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Red Blood Cell Products as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Red Blood Cell Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Red Blood Cell Products Sales by Region (2020-2025) & (Units)
Table 18. Global Red Blood Cell Products Sales Market Share by Region (2020-2025)
Table 19. Global Red Blood Cell Products Sales by Region (2026-2031) & (Units)
Table 20. Global Red Blood Cell Products Sales Market Share by Region (2026-2031)
Table 21. Global Red Blood Cell Products Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Red Blood Cell Products Revenue Market Share by Region (2020-2025)
Table 23. Global Red Blood Cell Products Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Red Blood Cell Products Revenue Market Share by Region (2026-2031)
Table 25. North America Red Blood Cell Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Red Blood Cell Products Sales by Country (2020-2025) & (Units)
Table 27. North America Red Blood Cell Products Sales by Country (2026-2031) & (Units)
Table 28. North America Red Blood Cell Products Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Red Blood Cell Products Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Red Blood Cell Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Red Blood Cell Products Sales by Country (2020-2025) & (Units)
Table 32. Europe Red Blood Cell Products Sales by Country (2026-2031) & (Units)
Table 33. Europe Red Blood Cell Products Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Red Blood Cell Products Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Red Blood Cell Products Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Red Blood Cell Products Sales by Region (2020-2025) & (Units)
Table 37. Asia Pacific Red Blood Cell Products Sales by Region (2026-2031) & (Units)
Table 38. Asia Pacific Red Blood Cell Products Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Red Blood Cell Products Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Red Blood Cell Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Red Blood Cell Products Sales by Country (2020-2025) & (Units)
Table 42. Latin America Red Blood Cell Products Sales by Country (2026-2031) & (Units)
Table 43. Latin America Red Blood Cell Products Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Red Blood Cell Products Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Red Blood Cell Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Red Blood Cell Products Sales by Country (2020-2025) & (Units)
Table 47. Middle East and Africa Red Blood Cell Products Sales by Country (2026-2031) & (Units)
Table 48. Middle East and Africa Red Blood Cell Products Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Red Blood Cell Products Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Red Blood Cell Products Sales (Units) by Type (2020-2025)
Table 51. Global Red Blood Cell Products Sales (Units) by Type (2026-2031)
Table 52. Global Red Blood Cell Products Sales Market Share by Type (2020-2025)
Table 53. Global Red Blood Cell Products Sales Market Share by Type (2026-2031)
Table 54. Global Red Blood Cell Products Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Red Blood Cell Products Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Red Blood Cell Products Revenue Market Share by Type (2020-2025)
Table 57. Global Red Blood Cell Products Revenue Market Share by Type (2026-2031)
Table 58. Global Red Blood Cell Products Price (US$/Unit) by Type (2020-2025)
Table 59. Global Red Blood Cell Products Price (US$/Unit) by Type (2026-2031)
Table 60. Global Red Blood Cell Products Sales (Units) by Application (2020-2025)
Table 61. Global Red Blood Cell Products Sales (Units) by Application (2026-2031)
Table 62. Global Red Blood Cell Products Sales Market Share by Application (2020-2025)
Table 63. Global Red Blood Cell Products Sales Market Share by Application (2026-2031)
Table 64. Global Red Blood Cell Products Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Red Blood Cell Products Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Red Blood Cell Products Revenue Market Share by Application (2020-2025)
Table 67. Global Red Blood Cell Products Revenue Market Share by Application (2026-2031)
Table 68. Global Red Blood Cell Products Price (US$/Unit) by Application (2020-2025)
Table 69. Global Red Blood Cell Products Price (US$/Unit) by Application (2026-2031)
Table 70. Emergent BioSolutions Company Information
Table 71. Emergent BioSolutions Description and Business Overview
Table 72. Emergent BioSolutions Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Emergent BioSolutions Red Blood Cell Products Product
Table 74. Emergent BioSolutions Recent Developments/Updates
Table 75. Kamada Company Information
Table 76. Kamada Description and Business Overview
Table 77. Kamada Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Kamada Red Blood Cell Products Product
Table 79. Kamada Recent Developments/Updates
Table 80. Takeda Pharmaceutical Company Information
Table 81. Takeda Pharmaceutical Description and Business Overview
Table 82. Takeda Pharmaceutical Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Takeda Pharmaceutical Red Blood Cell Products Product
Table 84. Takeda Pharmaceutical Recent Developments/Updates
Table 85. Kedrion Company Information
Table 86. Kedrion Description and Business Overview
Table 87. Kedrion Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Kedrion Red Blood Cell Products Product
Table 89. Kedrion Recent Developments/Updates
Table 90. Grifols Company Information
Table 91. Grifols Description and Business Overview
Table 92. Grifols Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Grifols Red Blood Cell Products Product
Table 94. Grifols Recent Developments/Updates
Table 95. Hemophilia Federation Europe Company Information
Table 96. Hemophilia Federation Europe Description and Business Overview
Table 97. Hemophilia Federation Europe Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Hemophilia Federation Europe Red Blood Cell Products Product
Table 99. Hemophilia Federation Europe Recent Developments/Updates
Table 100. CSL Behring Company Information
Table 101. CSL Behring Description and Business Overview
Table 102. CSL Behring Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. CSL Behring Red Blood Cell Products Product
Table 104. CSL Behring Recent Developments/Updates
Table 105. Octapharma Company Information
Table 106. Octapharma Description and Business Overview
Table 107. Octapharma Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Octapharma Red Blood Cell Products Product
Table 109. Octapharma Recent Developments/Updates
Table 110. LFB Group Company Information
Table 111. LFB Group Description and Business Overview
Table 112. LFB Group Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. LFB Group Red Blood Cell Products Product
Table 114. LFB Group Recent Developments/Updates
Table 115. American Red Cross Company Information
Table 116. American Red Cross Description and Business Overview
Table 117. American Red Cross Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. American Red Cross Red Blood Cell Products Product
Table 119. American Red Cross Recent Developments/Updates
Table 120. Biotest Company Information
Table 121. Biotest Description and Business Overview
Table 122. Biotest Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Biotest Red Blood Cell Products Product
Table 124. Biotest Recent Developments/Updates
Table 125. Sangamo Therapeutics Company Information
Table 126. Sangamo Therapeutics Description and Business Overview
Table 127. Sangamo Therapeutics Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Sangamo Therapeutics Red Blood Cell Products Product
Table 129. Sangamo Therapeutics Recent Developments/Updates
Table 130. China National Biotec Group Company Information
Table 131. China National Biotec Group Description and Business Overview
Table 132. China National Biotec Group Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. China National Biotec Group Red Blood Cell Products Product
Table 134. China National Biotec Group Recent Developments/Updates
Table 135. Hualan Biological Company Information
Table 136. Hualan Biological Description and Business Overview
Table 137. Hualan Biological Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Hualan Biological Red Blood Cell Products Product
Table 139. Hualan Biological Recent Developments/Updates
Table 140. Shanghai RAAS Blood Products Company Information
Table 141. Shanghai RAAS Blood Products Description and Business Overview
Table 142. Shanghai RAAS Blood Products Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Shanghai RAAS Blood Products Red Blood Cell Products Product
Table 144. Shanghai RAAS Blood Products Recent Developments/Updates
Table 145. Tiantan Biological Company Information
Table 146. Tiantan Biological Description and Business Overview
Table 147. Tiantan Biological Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Tiantan Biological Red Blood Cell Products Product
Table 149. Tiantan Biological Recent Developments/Updates
Table 150. Bohui Innovation Company Information
Table 151. Bohui Innovation Description and Business Overview
Table 152. Bohui Innovation Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Bohui Innovation Red Blood Cell Products Product
Table 154. Bohui Innovation Recent Developments/Updates
Table 155. Pilin Biological Company Information
Table 156. Pilin Biological Description and Business Overview
Table 157. Pilin Biological Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Pilin Biological Red Blood Cell Products Product
Table 159. Pilin Biological Recent Developments/Updates
Table 160. Weiguang Biological Company Information
Table 161. Weiguang Biological Description and Business Overview
Table 162. Weiguang Biological Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Weiguang Biological Red Blood Cell Products Product
Table 164. Weiguang Biological Recent Developments/Updates
Table 165. Boyaa Bio-pharmaceutical Company Information
Table 166. Boyaa Bio-pharmaceutical Description and Business Overview
Table 167. Boyaa Bio-pharmaceutical Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Boyaa Bio-pharmaceutical Red Blood Cell Products Product
Table 169. Boyaa Bio-pharmaceutical Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Red Blood Cell Products Distributors List
Table 173. Red Blood Cell Products Customers List
Table 174. Red Blood Cell Products Market Trends
Table 175. Red Blood Cell Products Market Drivers
Table 176. Red Blood Cell Products Market Challenges
Table 177. Red Blood Cell Products Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Red Blood Cell Products
Figure 2. Global Red Blood Cell Products Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Red Blood Cell Products Market Share by Type: 2024 & 2031
Figure 4. Red Blood Cell Suspension Product Picture
Figure 5. Concentrated Red Blood Cells Product Picture
Figure 6. Washed Red Blood Cells Product Picture
Figure 7. Irradiated Red Blood Cells Product Picture
Figure 8. Frozen Red Blood Cells Product Picture
Figure 9. Others Product Picture
Figure 10. Global Red Blood Cell Products Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Red Blood Cell Products Market Share by Application: 2024 & 2031
Figure 12. Anemia Treatment
Figure 13. Acute Hemorrhage
Figure 14. Blood Disease Supportive Treatment
Figure 15. Special Disease Management
Figure 16. Global Red Blood Cell Products Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Red Blood Cell Products Market Size (2020-2031) & (US$ Million)
Figure 18. Global Red Blood Cell Products Sales (2020-2031) & (Units)
Figure 19. Global Red Blood Cell Products Average Price (US$/Unit) & (2020-2031)
Figure 20. Red Blood Cell Products Report Years Considered
Figure 21. Red Blood Cell Products Sales Share by Manufacturers in 2024
Figure 22. Global Red Blood Cell Products Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Red Blood Cell Products Players: Market Share by Revenue in Red Blood Cell Products in 2024
Figure 24. Red Blood Cell Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Red Blood Cell Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Red Blood Cell Products Sales Market Share by Country (2020-2031)
Figure 27. North America Red Blood Cell Products Revenue Market Share by Country (2020-2031)
Figure 28. United States Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Red Blood Cell Products Sales Market Share by Country (2020-2031)
Figure 31. Europe Red Blood Cell Products Revenue Market Share by Country (2020-2031)
Figure 32. Germany Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Red Blood Cell Products Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Red Blood Cell Products Revenue Market Share by Region (2020-2031)
Figure 39. China Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Red Blood Cell Products Sales Market Share by Country (2020-2031)
Figure 47. Latin America Red Blood Cell Products Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Colombia Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Red Blood Cell Products Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Red Blood Cell Products Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Red Blood Cell Products by Type (2020-2031)
Figure 58. Global Revenue Market Share of Red Blood Cell Products by Type (2020-2031)
Figure 59. Global Red Blood Cell Products Price (US$/Unit) by Type (2020-2031)
Figure 60. Global Sales Market Share of Red Blood Cell Products by Application (2020-2031)
Figure 61. Global Revenue Market Share of Red Blood Cell Products by Application (2020-2031)
Figure 62. Global Red Blood Cell Products Price (US$/Unit) by Application (2020-2031)
Figure 63. Red Blood Cell Products Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Red Blood Cell Products Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Red Blood Cell Products Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Red Blood Cell Products Market Competitive Situation by Manufacturers in 2024
Table 4. Global Red Blood Cell Products Sales (Units) of Key Manufacturers (2020-2025)
Table 5. Global Red Blood Cell Products Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Red Blood Cell Products Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Red Blood Cell Products Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Red Blood Cell Products Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Red Blood Cell Products, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Red Blood Cell Products, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Red Blood Cell Products, Product Type & Application
Table 12. Global Key Manufacturers of Red Blood Cell Products, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Red Blood Cell Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Red Blood Cell Products as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Red Blood Cell Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Red Blood Cell Products Sales by Region (2020-2025) & (Units)
Table 18. Global Red Blood Cell Products Sales Market Share by Region (2020-2025)
Table 19. Global Red Blood Cell Products Sales by Region (2026-2031) & (Units)
Table 20. Global Red Blood Cell Products Sales Market Share by Region (2026-2031)
Table 21. Global Red Blood Cell Products Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Red Blood Cell Products Revenue Market Share by Region (2020-2025)
Table 23. Global Red Blood Cell Products Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Red Blood Cell Products Revenue Market Share by Region (2026-2031)
Table 25. North America Red Blood Cell Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Red Blood Cell Products Sales by Country (2020-2025) & (Units)
Table 27. North America Red Blood Cell Products Sales by Country (2026-2031) & (Units)
Table 28. North America Red Blood Cell Products Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Red Blood Cell Products Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Red Blood Cell Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Red Blood Cell Products Sales by Country (2020-2025) & (Units)
Table 32. Europe Red Blood Cell Products Sales by Country (2026-2031) & (Units)
Table 33. Europe Red Blood Cell Products Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Red Blood Cell Products Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Red Blood Cell Products Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Red Blood Cell Products Sales by Region (2020-2025) & (Units)
Table 37. Asia Pacific Red Blood Cell Products Sales by Region (2026-2031) & (Units)
Table 38. Asia Pacific Red Blood Cell Products Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Red Blood Cell Products Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Red Blood Cell Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Red Blood Cell Products Sales by Country (2020-2025) & (Units)
Table 42. Latin America Red Blood Cell Products Sales by Country (2026-2031) & (Units)
Table 43. Latin America Red Blood Cell Products Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Red Blood Cell Products Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Red Blood Cell Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Red Blood Cell Products Sales by Country (2020-2025) & (Units)
Table 47. Middle East and Africa Red Blood Cell Products Sales by Country (2026-2031) & (Units)
Table 48. Middle East and Africa Red Blood Cell Products Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Red Blood Cell Products Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Red Blood Cell Products Sales (Units) by Type (2020-2025)
Table 51. Global Red Blood Cell Products Sales (Units) by Type (2026-2031)
Table 52. Global Red Blood Cell Products Sales Market Share by Type (2020-2025)
Table 53. Global Red Blood Cell Products Sales Market Share by Type (2026-2031)
Table 54. Global Red Blood Cell Products Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Red Blood Cell Products Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Red Blood Cell Products Revenue Market Share by Type (2020-2025)
Table 57. Global Red Blood Cell Products Revenue Market Share by Type (2026-2031)
Table 58. Global Red Blood Cell Products Price (US$/Unit) by Type (2020-2025)
Table 59. Global Red Blood Cell Products Price (US$/Unit) by Type (2026-2031)
Table 60. Global Red Blood Cell Products Sales (Units) by Application (2020-2025)
Table 61. Global Red Blood Cell Products Sales (Units) by Application (2026-2031)
Table 62. Global Red Blood Cell Products Sales Market Share by Application (2020-2025)
Table 63. Global Red Blood Cell Products Sales Market Share by Application (2026-2031)
Table 64. Global Red Blood Cell Products Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Red Blood Cell Products Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Red Blood Cell Products Revenue Market Share by Application (2020-2025)
Table 67. Global Red Blood Cell Products Revenue Market Share by Application (2026-2031)
Table 68. Global Red Blood Cell Products Price (US$/Unit) by Application (2020-2025)
Table 69. Global Red Blood Cell Products Price (US$/Unit) by Application (2026-2031)
Table 70. Emergent BioSolutions Company Information
Table 71. Emergent BioSolutions Description and Business Overview
Table 72. Emergent BioSolutions Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Emergent BioSolutions Red Blood Cell Products Product
Table 74. Emergent BioSolutions Recent Developments/Updates
Table 75. Kamada Company Information
Table 76. Kamada Description and Business Overview
Table 77. Kamada Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Kamada Red Blood Cell Products Product
Table 79. Kamada Recent Developments/Updates
Table 80. Takeda Pharmaceutical Company Information
Table 81. Takeda Pharmaceutical Description and Business Overview
Table 82. Takeda Pharmaceutical Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Takeda Pharmaceutical Red Blood Cell Products Product
Table 84. Takeda Pharmaceutical Recent Developments/Updates
Table 85. Kedrion Company Information
Table 86. Kedrion Description and Business Overview
Table 87. Kedrion Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Kedrion Red Blood Cell Products Product
Table 89. Kedrion Recent Developments/Updates
Table 90. Grifols Company Information
Table 91. Grifols Description and Business Overview
Table 92. Grifols Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Grifols Red Blood Cell Products Product
Table 94. Grifols Recent Developments/Updates
Table 95. Hemophilia Federation Europe Company Information
Table 96. Hemophilia Federation Europe Description and Business Overview
Table 97. Hemophilia Federation Europe Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Hemophilia Federation Europe Red Blood Cell Products Product
Table 99. Hemophilia Federation Europe Recent Developments/Updates
Table 100. CSL Behring Company Information
Table 101. CSL Behring Description and Business Overview
Table 102. CSL Behring Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. CSL Behring Red Blood Cell Products Product
Table 104. CSL Behring Recent Developments/Updates
Table 105. Octapharma Company Information
Table 106. Octapharma Description and Business Overview
Table 107. Octapharma Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Octapharma Red Blood Cell Products Product
Table 109. Octapharma Recent Developments/Updates
Table 110. LFB Group Company Information
Table 111. LFB Group Description and Business Overview
Table 112. LFB Group Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. LFB Group Red Blood Cell Products Product
Table 114. LFB Group Recent Developments/Updates
Table 115. American Red Cross Company Information
Table 116. American Red Cross Description and Business Overview
Table 117. American Red Cross Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. American Red Cross Red Blood Cell Products Product
Table 119. American Red Cross Recent Developments/Updates
Table 120. Biotest Company Information
Table 121. Biotest Description and Business Overview
Table 122. Biotest Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Biotest Red Blood Cell Products Product
Table 124. Biotest Recent Developments/Updates
Table 125. Sangamo Therapeutics Company Information
Table 126. Sangamo Therapeutics Description and Business Overview
Table 127. Sangamo Therapeutics Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Sangamo Therapeutics Red Blood Cell Products Product
Table 129. Sangamo Therapeutics Recent Developments/Updates
Table 130. China National Biotec Group Company Information
Table 131. China National Biotec Group Description and Business Overview
Table 132. China National Biotec Group Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. China National Biotec Group Red Blood Cell Products Product
Table 134. China National Biotec Group Recent Developments/Updates
Table 135. Hualan Biological Company Information
Table 136. Hualan Biological Description and Business Overview
Table 137. Hualan Biological Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Hualan Biological Red Blood Cell Products Product
Table 139. Hualan Biological Recent Developments/Updates
Table 140. Shanghai RAAS Blood Products Company Information
Table 141. Shanghai RAAS Blood Products Description and Business Overview
Table 142. Shanghai RAAS Blood Products Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Shanghai RAAS Blood Products Red Blood Cell Products Product
Table 144. Shanghai RAAS Blood Products Recent Developments/Updates
Table 145. Tiantan Biological Company Information
Table 146. Tiantan Biological Description and Business Overview
Table 147. Tiantan Biological Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Tiantan Biological Red Blood Cell Products Product
Table 149. Tiantan Biological Recent Developments/Updates
Table 150. Bohui Innovation Company Information
Table 151. Bohui Innovation Description and Business Overview
Table 152. Bohui Innovation Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Bohui Innovation Red Blood Cell Products Product
Table 154. Bohui Innovation Recent Developments/Updates
Table 155. Pilin Biological Company Information
Table 156. Pilin Biological Description and Business Overview
Table 157. Pilin Biological Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Pilin Biological Red Blood Cell Products Product
Table 159. Pilin Biological Recent Developments/Updates
Table 160. Weiguang Biological Company Information
Table 161. Weiguang Biological Description and Business Overview
Table 162. Weiguang Biological Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Weiguang Biological Red Blood Cell Products Product
Table 164. Weiguang Biological Recent Developments/Updates
Table 165. Boyaa Bio-pharmaceutical Company Information
Table 166. Boyaa Bio-pharmaceutical Description and Business Overview
Table 167. Boyaa Bio-pharmaceutical Red Blood Cell Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Boyaa Bio-pharmaceutical Red Blood Cell Products Product
Table 169. Boyaa Bio-pharmaceutical Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Red Blood Cell Products Distributors List
Table 173. Red Blood Cell Products Customers List
Table 174. Red Blood Cell Products Market Trends
Table 175. Red Blood Cell Products Market Drivers
Table 176. Red Blood Cell Products Market Challenges
Table 177. Red Blood Cell Products Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Red Blood Cell Products
Figure 2. Global Red Blood Cell Products Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Red Blood Cell Products Market Share by Type: 2024 & 2031
Figure 4. Red Blood Cell Suspension Product Picture
Figure 5. Concentrated Red Blood Cells Product Picture
Figure 6. Washed Red Blood Cells Product Picture
Figure 7. Irradiated Red Blood Cells Product Picture
Figure 8. Frozen Red Blood Cells Product Picture
Figure 9. Others Product Picture
Figure 10. Global Red Blood Cell Products Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Red Blood Cell Products Market Share by Application: 2024 & 2031
Figure 12. Anemia Treatment
Figure 13. Acute Hemorrhage
Figure 14. Blood Disease Supportive Treatment
Figure 15. Special Disease Management
Figure 16. Global Red Blood Cell Products Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Red Blood Cell Products Market Size (2020-2031) & (US$ Million)
Figure 18. Global Red Blood Cell Products Sales (2020-2031) & (Units)
Figure 19. Global Red Blood Cell Products Average Price (US$/Unit) & (2020-2031)
Figure 20. Red Blood Cell Products Report Years Considered
Figure 21. Red Blood Cell Products Sales Share by Manufacturers in 2024
Figure 22. Global Red Blood Cell Products Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Red Blood Cell Products Players: Market Share by Revenue in Red Blood Cell Products in 2024
Figure 24. Red Blood Cell Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Red Blood Cell Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Red Blood Cell Products Sales Market Share by Country (2020-2031)
Figure 27. North America Red Blood Cell Products Revenue Market Share by Country (2020-2031)
Figure 28. United States Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Red Blood Cell Products Sales Market Share by Country (2020-2031)
Figure 31. Europe Red Blood Cell Products Revenue Market Share by Country (2020-2031)
Figure 32. Germany Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Red Blood Cell Products Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Red Blood Cell Products Revenue Market Share by Region (2020-2031)
Figure 39. China Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Red Blood Cell Products Sales Market Share by Country (2020-2031)
Figure 47. Latin America Red Blood Cell Products Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Colombia Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Red Blood Cell Products Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Red Blood Cell Products Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Red Blood Cell Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Red Blood Cell Products by Type (2020-2031)
Figure 58. Global Revenue Market Share of Red Blood Cell Products by Type (2020-2031)
Figure 59. Global Red Blood Cell Products Price (US$/Unit) by Type (2020-2031)
Figure 60. Global Sales Market Share of Red Blood Cell Products by Application (2020-2031)
Figure 61. Global Revenue Market Share of Red Blood Cell Products by Application (2020-2031)
Figure 62. Global Red Blood Cell Products Price (US$/Unit) by Application (2020-2031)
Figure 63. Red Blood Cell Products Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232